Source: Empower Clinics Inc.
  • Empower Clinics (CBDT) will be conducting a non-brokered private placement for aggregate gross proceeds of up to $3,000,000
  • The company will issue units at a price of $0.20 and unsecured convertible debenture units at a price of $1,000 per unit
  • Each debenture unit will consist of one senior unsecured convertible debenture and 5,000 warrants
  • The debentures will pay 6 per cent interest per annum and will mature two years from the date of issuance
  • Empower is a healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care
  • Empower Clinics Inc. (CBDT) is up 5.48 per cent, trading at C$0.385 per share at 10:35 am EST

Empower Clinics (CBDT) will be conducting a non-brokered private placement for aggregate gross proceeds of up to $3,000,000.

The company will issue units at a price of $0.20 and unsecured convertible debenture units at a price of $1,000 per unit.

Each unit will consist of one common share and one common share purchase warrant. Each warrant will entitle the holder to purchase one share at a price of $0.30 for a period of two years.

Each debenture unit will consist of one senior unsecured convertible debenture and 5,000 warrants. The debentures will bear interest at the rate of 6.0 per cent per annum and will mature two years from the date of issuance. The debentures may be converted into shares at any time prior to the maturity date at a conversion price of $0.20 per share.

The closing of the offering will occur on or about January 6th and is subject to receipt of all necessary corporate and regulatory approvals.

Proceeds will be used for advancing the company’s growth plans, working capital purposes and general administrative expenses.

Units and debentures issued in connection with the financing will be subject to a four-month hold period under applicable Canadian securities laws.

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Empower is aggressively growing its clinical and digital presence across North America.

Empower Clinics Inc. (CBDT) is up 5.48 per cent, trading at C$0.385 per share at 10:35 am EST.

More From The Market Online

Cancer fighter Theralase aims to turn lab wins into human trials

Theralase (TSXV:TLT) begins Good Laboratory Practice toxicology analysis of Rutherrin, its drug candidate to target and destroy cancer cells.

Restart Life Sciences serves up exponential revenue growth

Restart Life Sciences (CSE:HEAL) more than doubled revenue at stable profit margins in Q2 2026 amid several promising commercial activations.
The Market Online Video

NurExone Biologic progresses towards a new regenerative therapy and sets sights on a potential NASDAQ listing

NurExone CEO Dr. Lior Shaltiel discusses U.S. exosome manufacturing, Mexico expansion, ExoPTEN and plans for a potential U.S. listing.
The Market Online Video

Med-X targets global pest control market with Nature-Cide

Med-X CEO Matthew Mills discusses Nature-Cide, professional pest control partnerships, global expansion and the company’s planned Nasdaq listing.